NOS3 and myeloid sarcoma: Recent studies also demonstrate that NOS3-knockout mice develop dyslipidemia, insulin resistance, decreased insulin-dependent glucose uptake in skeletal muscles and adipose tissue, and hypertension, mimicking the phenotype of MS [2–5].